Comment on

• Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.

  Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Radiother Oncol. 2018 Feb;126(2):257-262. doi: 10.1016/j.radonc.2017.10.025. Epub 2017 Nov 3. Radiother Oncol. 2018. PMID: 29103826 Clinical Trial.
• Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?

  Picardi C, Perret I, Miralbell R, Zilli T. Picardi C, et al. Cancer Treat Rev. 2018 Jan;62:91-96. doi: 10.1016/j.ctrv.2017.11.004. Epub 2017 Nov 14. Cancer Treat Rev. 2018. PMID: 29178983
• Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

  Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA. Hwang WL, et al. JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230. Epub 2018 May 10. JAMA Oncol. 2018. PMID: 29372236 Free PMC article.
• Postoperative Hypofractionated Radiation Therapy in Prostate Carcinoma: A Systematic Review.

  Siepe G, Buwenge M, Nguyen NP, Macchia G, Deodato F, Cilla S, Mattiucci GC, Capocaccia I, Cammelli S, Guido A, Arcelli A, Ntreta M, Guerri S, Morganti AG. Siepe G, et al. Anticancer Res. 2018 Mar;38(3):1221-1230. doi: 10.21873/anticanres.12343. Anticancer Res. 2018. PMID: 29491044